NCT02463695

Brief Summary

The pathophysiology of vertigo is complex and usually requires specialist involvement. During the diagnostic process, patients commonly undergo tests which assess the integrity of the gaze and posture stabilisation mechanisms involving the inner ear (vestibular system), the visual systems and the subconscious neural pathways that interconnect them. Whilst these tests are useful they fail to provide information concerning the neural connections to the cortex and therefore neglect the perceptual aspects of disequilibrium. At present the possibility of routine examination of these higher projections remains elusive as no practical alternatives to the expensive functional magnetic resonance imaging systems exist. However, recently a novel method of recording cortical vestibular evoked potentials (CVEPs) has been described. CVEPs utilise an existing method used to interrogate cortical projections from the auditory system in which sound waves stimulate the inner ear and the resulting electrical responses from the brain are recorded. The recent breakthrough is in the realisation that these responses also contain information from the balance organs and therefore are a direct measure of cortical processing of the vestibular inputs. Current evidence shows that CVEPs are present in the normal population and absent in patients with no vestibular function. The primary aim for this study is to extend the patient cohort to include those who have a vestibular injury but retain residual function. Patients going through standard testing will have also have CVEPs on both ears providing seminal information into the effect of injury to the peripheral vestibular system on the cortical pathways. Furthermore, by following the cohort through their complete management pathway it will be possible to ascertain if the CVEP can be used to predict rehabilitation outcome success.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
51

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2014

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 14, 2014

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

May 28, 2015

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 4, 2015

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2016

Completed
Last Updated

April 29, 2026

Status Verified

April 1, 2026

Enrollment Period

1.9 years

First QC Date

May 28, 2015

Last Update Submit

April 23, 2026

Conditions

Keywords

partial vestibular deficitcortical vestibular evoked potential

Outcome Measures

Primary Outcomes (1)

  • The degree of change of cortical vestibular evoked potential measured by amplitude (in microvolts)

    6 months

Secondary Outcomes (1)

  • The time interval between the stimulation and response (latency) of cortical vestibular evoked potential

    6 months

Study Arms (2)

vestibular deficit

EXPERIMENTAL

* Initial clinical assessment including otoneurological examination, pure tone audiometry, tympanometry vestibular screening tests and Magnetic Resonance Imaging as clinically indicated. * The cortical vestibular evoked potentials will add approximately add an extra 30 minutes to the test sequence but is minimally invasive and will not cause any pain or discomfort. It will be conducted on both the affected and non-affected ears.

Procedure: cortical vestibular evoked potentials (CVEPs)

otologically normal controll

ACTIVE COMPARATOR

Normative data will be collected from 36 normal ears from subjects that have no history of audiovestibular symptoms and are not being investigated for any balance disorders. The cortical vestibular evoked potentials will be recorded from both ears

Procedure: cortical vestibular evoked potentials (CVEPs)

Interventions

CVEPs utilise an existing method used to interrogate cortical projections from the auditory system in which sound waves stimulate the inner ear and the resulting electrical responses from the brain are recorded (known as Cortical Auditory Evoked Potentials CAEPs)

Also known as: Cortical auditory evoked potential
otologically normal controllvestibular deficit

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Vestibular deficit Group:
  • Over 18 years of age
  • Can provide informed consent
  • Deemed to have an otoneurological cause for their symptoms (true vertigo, room spinning even when head is still)
  • No middle ear pathology
  • NORMATIVE GROUP:
  • Over 18 years of age
  • Can provide informed consent
  • No previous otoneurological history

You may not qualify if:

  • VESTIBULAR DEFICIT GROUP PATIENTS
  • Participants under the age of 18
  • Participants unable to provide informed consent
  • Patients not deemed to have an otoneurological cause for their symptoms
  • Patients with middle ear pathology
  • NORMATIVE GROUP:
  • Previous history of problems with hearing and or balance
  • Participants under the age of 18
  • Participants unable to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sheffield Teaching Hospitals NHS Trust

Sheffield, South Yorkshire, S10 2JF, United Kingdom

Location

MeSH Terms

Conditions

Vestibular Neuronitis

Condition Hierarchy (Ancestors)

Vestibulocochlear Nerve DiseasesRetrocochlear DiseasesEar DiseasesOtorhinolaryngologic DiseasesCranial Nerve DiseasesNervous System Diseases

Study Officials

  • Jaswinder S Sandhu, Dr

    Sheffield Teaching Hospitals NHS Foundation Trust

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 28, 2015

First Posted

June 4, 2015

Study Start

October 14, 2014

Primary Completion

August 31, 2016

Study Completion

August 31, 2016

Last Updated

April 29, 2026

Record last verified: 2026-04

Locations